Diagenode

News

NEW POSTER
December 3, 2013

As the role of the changes in the epigenome is becoming more and more revealed there are a growing number of scientific papers reporting epigenetic/epigenomic studies. Malicious epigenomic alterations can be the reason behind widespread social problems like different types of cancers (eg. breast cancer), as well as rare diseases like ICF (Immunodeficiency, Centromeric region instability, Facial anomalies) syndrome, the like of which often not interest the medical industry therefore the diagnostic/therapeutic products are underdeveloped or non-existent at all. Such chromatin diseases (Rett syndrome, ATRX syndrome, FSHD, ICF syndrome) are the subject of the DisChrom project (FP7 project under the grant agreement PTN-GA-2009-238242) in which we participate.

Download the poster

Events

  • Symposium: "Signaling through Chromatin"
    Grenoble, France
    Oct 2-Oct 4, 2023
  • EMBL Symposium: The non-coding genome
    Heidelberg, Germany
    Oct 11-Oct 14, 2023
  • IUBMB
    Crete, Greece
    Oct 15-Oct 20, 2023
 See all events

News

 See all news


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics